GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$172.36
+0 (+0%)
At Close: Dec 22, 2023
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $172.36 $172.36 Friday, 22nd Dec 2023 RETA stock ended at $172.36. During the day the stock fluctuated 0% from a day low at $172.36 to a day high of $172.36.
90 days $172.32 $172.46
52 weeks $26.26 $172.46

Historical RETA prices

Date Open High Low Close Volume
2023-10-12 $172.36 $172.36 $172.36 $172.36 0
2023-10-11 $172.36 $172.36 $172.36 $172.36 0
2023-10-10 $172.36 $172.36 $172.36 $172.36 0
2023-10-09 $172.36 $172.36 $172.36 $172.36 0
2023-10-06 $172.36 $172.36 $172.36 $172.36 0
2023-10-05 $172.36 $172.36 $172.36 $172.36 0
2023-10-04 $172.36 $172.36 $172.36 $172.36 0
2023-10-03 $172.36 $172.36 $172.36 $172.36 0
2023-10-02 $172.36 $172.36 $172.36 $172.36 0
2023-09-29 $172.36 $172.36 $172.36 $172.36 0
2023-09-28 $172.36 $172.36 $172.36 $172.36 0
2023-09-27 $172.36 $172.36 $172.36 $172.36 0
2023-09-26 $172.36 $172.36 $172.36 $172.36 0
2023-09-25 $172.34 $172.46 $172.32 $172.36 1 909 215
2023-09-22 $172.29 $172.33 $172.25 $172.32 661 623
2023-09-21 $172.22 $172.36 $172.12 $172.17 1 887 393
2023-09-20 $172.10 $172.21 $172.10 $172.21 443 586
2023-09-19 $172.00 $172.15 $172.00 $172.11 339 095
2023-09-18 $172.00 $172.08 $171.76 $172.05 466 023
2023-09-15 $172.05 $172.15 $171.82 $172.00 788 924
2023-09-14 $172.00 $172.10 $171.98 $172.06 331 846
2023-09-13 $172.00 $172.10 $171.97 $172.00 1 049 691
2023-09-12 $170.54 $172.05 $170.32 $171.98 1 679 766
2023-09-11 $170.41 $171.12 $170.37 $170.94 1 093 294
2023-09-08 $169.75 $170.36 $169.70 $170.32 545 055
Click to get the best stock tips daily for free!

About RETA

RETA Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated ... RETA Profile

Golden Star

Ticker Date Change Price
ITCI Apr 05 12.05% $68.44
AKR Apr 05 0.665% $16.53
SARK Mar 28 16.07% $26.88
ARCC Mar 25 1.04% $20.12
STT Mar 19 0.262% $72.62
GGB Mar 19 0.468% $4.27
CAG Mar 18 7.16% $28.22
JBI Mar 15 1.29% $14.72
MASI Mar 14 3.34% $132.20
CMC Mar 14 5.04% $53.19
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT